University of Washington spinout Icosavax has filed for an initial public offering on the Nasdaq Global Select Market, with financial terms yet to be set.

The Samsung and Qualcomm-backed cybersecurity technology producer added over $180m to a $1.22bn offering last week.

The valuation is double that at which the Alphabet, Comcast and Axel Springer-backed, neighbourhood-focused social network last raised money.

The Tencent-backed geospatial data technology developer will acquire a Nasdaq listing through the transaction, giving it an $850m implied enterprise value.

Swisscom and Hitachi-backed genomic data technology provider Sophia has filed to go public following some $250m in venture funding.

Mitsui and Nan Fung could exit the rare disease drug developer, which is set to float on the Nasdaq Global Select Market having set a $100m placeholder target.

Sauce Labs has purchased the error reporting tool developer, which had reportedly raised over $6m from investors including 60East Technologies.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

Ant Group is set to score an exit when the financial technology platform operator lists in Korea next month in an IPO sized at up to $1.5bn.

The BMW, Dell and Robert Bosch-backed manufacturing services platform has added just over $44m to its initial public offering, its shares having risen 58%.